307 related articles for article (PubMed ID: 16410546)
21. New Myc-interacting proteins: a second Myc network emerges.
Sakamuro D; Prendergast GC
Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.
Dezfouli S; Bakke A; Huang J; Wynshaw-Boris A; Hurlin PJ
Mol Cell Biol; 2006 Mar; 26(6):2080-92. PubMed ID: 16507988
[TBL] [Abstract][Full Text] [Related]
23. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
[TBL] [Abstract][Full Text] [Related]
24. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
[TBL] [Abstract][Full Text] [Related]
25. The MAX-interacting transcription factor network.
Hurlin PJ; Huang J
Semin Cancer Biol; 2006 Aug; 16(4):265-74. PubMed ID: 16908182
[TBL] [Abstract][Full Text] [Related]
26. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek L; Jucker R; Panacchia L; Ricordy R; Tatò F; Nasi S
Cancer Res; 2002 Jun; 62(12):3507-10. PubMed ID: 12067996
[TBL] [Abstract][Full Text] [Related]
27. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
28. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
29. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.
Bouchard C; Dittrich O; Kiermaier A; Dohmann K; Menkel A; Eilers M; Lüscher B
Genes Dev; 2001 Aug; 15(16):2042-7. PubMed ID: 11511535
[TBL] [Abstract][Full Text] [Related]
31. The Mad side of the Max network: antagonizing the function of Myc and more.
Rottmann S; Lüscher B
Curr Top Microbiol Immunol; 2006; 302():63-122. PubMed ID: 16620026
[TBL] [Abstract][Full Text] [Related]
32. Identification of Max binding protein as a novel binding protein of Nck1 and characterization of its role in inhibiting human liver cancer SK-HEP-1 cells.
Zhou Q; Huang T; Wang YF; Zhang KS; Chen D; Peng BG
Chin Med J (Engl); 2012 Sep; 125(18):3336-9. PubMed ID: 22964333
[TBL] [Abstract][Full Text] [Related]
33. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
Link JM; Hurlin PJ
Biochim Biophys Acta; 2015 May; 1849(5):554-62. PubMed ID: 24731854
[TBL] [Abstract][Full Text] [Related]
34. Structural aspects of interactions within the Myc/Max/Mad network.
Nair SK; Burley SK
Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
[TBL] [Abstract][Full Text] [Related]
35. MYC needs MNT.
Link JM; Hurlin PJ
Cell Cycle; 2013 Feb; 12(3):385-6. PubMed ID: 23324353
[No Abstract] [Full Text] [Related]
36. Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.
Jeong KC; Ahn KO; Yang CH
Mol Biosyst; 2010 Aug; 6(8):1503-9. PubMed ID: 20485733
[TBL] [Abstract][Full Text] [Related]
37. The Myc/Max/Mad network and the transcriptional control of cell behavior.
Grandori C; Cowley SM; James LP; Eisenman RN
Annu Rev Cell Dev Biol; 2000; 16():653-99. PubMed ID: 11031250
[TBL] [Abstract][Full Text] [Related]
38. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
[TBL] [Abstract][Full Text] [Related]
39. Mad1 is a transcriptional repressor of Bcl-6.
Lee SC; Bottaro A; Chen L; Insel RA
Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
[TBL] [Abstract][Full Text] [Related]
40. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
James L; Eisenman RN
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]